L. Staudacher

Most-cited papers

1. Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience.

   L. Staudacher, P. Cottu, V. Diéras, A. Vincent-Salomon +6 more

   2011Annals of Oncology91 citations Open access

   Semantic Scholar

   Save

2. Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery.

   W. Cacheux, T. Boisserie, L. Staudacher, O. Vignaux +6 more

   2008Annals of Oncology77 citations Open access

   Semantic Scholar

   Save

3. Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)

   Nieves Martínez Chanzá, Louisa Soukane, P. Barthélémy, A. Carnot +16 more

   2021BMC Cancer18 citations Open access

   Semantic Scholar

   Save

4. Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial

   Jérémy Blanc, A. Carnot, P. Barthélémy, V. Casert +15 more

   2025Journal for ImmunoTherapy of Cancer10 citations Open access

   Semantic Scholar

   Save

5. 659MO Avelumab (A) as the basis of neoadjuvant chemotherapy (NAC) regimen in platinum eligible and ineligible patients (pts) with non-metastatic muscle invasive bladder cancer (NM-MIBC)

   N. M. Chanzá, A. Carnot, P. Barthélémy, V. Casert +16 more

   2021Annals of Oncology7 citations Open access

   Semantic Scholar

   Save

6. Avelumab (A) as neoadjuvant therapy in patients (pts) with muscle-invasive urothelial carcinoma (MIUC): Survival data of AURA trial, Oncodistinct 004.

   Jérémy Blanc, A. Carnot, P. Barthélémy, V. Casert +13 more

   2024Journal of Clinical Oncology6 citations Open access

   Semantic Scholar

   Save

7. Anastomotic dehiscence during treatment with bevacizumab 5 years after colo-anal anastomosis with proposition for management without stopping chemotherapy.

   C. Eveno, P. Soyer, Luis Augusto Teixeira, L. Staudacher +1 more

   2011Clinics And Research in Hepatology and Gastroenterology4 citations

   Semantic Scholar

   Save

8. [Targeted agents in the treatment of lung cancer].

   L. Staudacher, L. Teixeira, E. Kempf, G. Rousseau-Bussac +6 more

   2012Pathologie et biologie2 citations

   Semantic Scholar

   Save

9. Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

   J. Trédaniel, L. Staudacher, L. Teixeira, S. Sebbagh +2 more

   20101 citations Open access

   Semantic Scholar

   Save

10. Performance of 18FDG-PET in the management of non-metastatic HIV+ anal squamous cell carcinoma (ASCC).

    N. B. Hamed, G. Deplanque, Raïd Kassis, M. Gatineau +15 more

    20170 citations

    Semantic Scholar

    Save

11. 467 Platinum-based chemotherapy in triple-negative metastatic breast cancer: results of the Institut Curie experience with cisplatinum and ifosfamide

    L. Staudacher, P. Cottu, V. Diéras, A. Salomon +4 more

    20100 citations

    Semantic Scholar

    Save

12. Update : Vinorelbine in the Treatment of non-small-cell Lung cancer

    J. Trédaniel, L. Staudacher, L. Teixeira, S. Sebbagh +2 more

    20100 citations

    Semantic Scholar

    Save

13. 5053 Platinum-based chemotherapy in triple-negative metastatic breast cancer: results of the Institut Curie experience

    L. Staudacher, P. Cottu, V. Diéras, A. Vincent-Salomon +5 more

    20090 citations

    Semantic Scholar

    Save